[HTML][HTML] Nanomedicine platform for targeting activated neutrophils and neutrophil–platelet complexes using an α1-antitrypsin-derived peptide motif
Targeted drug delivery to disease-associated activated neutrophils can provide novel
therapeutic opportunities while avoiding systemic effects on immune functions. We created a …
therapeutic opportunities while avoiding systemic effects on immune functions. We created a …
[HTML][HTML] Nanomedicine platform for targeting activated neutrophils and neutrophil–platelet complexes using an α1-antitrypsin-derived peptide motif
MA Cruz, D Bohinc, EA Andraska, J Alvikas… - Nature …, 2022 - ncbi.nlm.nih.gov
Targeted drug delivery to disease-associated activated neutrophils can provide novel
therapeutic opportunities while avoiding systemic effects on immune functions. We created a …
therapeutic opportunities while avoiding systemic effects on immune functions. We created a …
Nanomedicine platform for targeting activated neutrophils and neutrophil-platelet complexes using an α1-antitrypsin-derived peptide motif.
MA Cruz, D Bohinc, EA Andraska, J Alvikas… - Nature …, 2022 - europepmc.org
Targeted drug delivery to disease-associated activated neutrophils can provide novel
therapeutic opportunities while avoiding systemic effects on immune functions. We created a …
therapeutic opportunities while avoiding systemic effects on immune functions. We created a …
Nanomedicine platform for targeting activated neutrophils and neutrophil-platelet complexes using an α1-antitrypsin-derived peptide motif.
MA Cruz, D Bohinc, EA Andraska, J Alvikas… - Nature …, 2022 - escholarship.org
Targeted drug delivery to disease-associated activated neutrophils can provide novel
therapeutic opportunities while avoiding systemic effects on immune functions. We created a …
therapeutic opportunities while avoiding systemic effects on immune functions. We created a …
Nanomedicine platform for targeting activated neutrophils and neutrophil-platelet complexes using an α1-antitrypsin-derived peptide motif
MA Cruz, D Bohinc, EA Andraska… - Nature …, 2022 - ui.adsabs.harvard.edu
Targeted drug delivery to disease-associated activated neutrophils can provide novel
therapeutic opportunities while avoiding systemic effects on immune functions. We created a …
therapeutic opportunities while avoiding systemic effects on immune functions. We created a …
Nanomedicine platform for targeting activated neutrophils and neutrophil-platelet complexes using an α1-antitrypsin-derived peptide motif
MA Cruz, D Bohinc, EA Andraska… - Nature …, 2022 - pubmed.ncbi.nlm.nih.gov
Targeted drug delivery to disease-associated activated neutrophils can provide novel
therapeutic opportunities while avoiding systemic effects on immune functions. We created a …
therapeutic opportunities while avoiding systemic effects on immune functions. We created a …